Katrina Lee, MD, FAAD
SESSIONS
U043 Management and Special Considerations in Unique Hidradenitis Suppurativa Populations: A Focus on Down Syndrome, Exogenous Hormone Use, and the Elderly
Mar 28, 2026
•
7:30 AM - 8:30 AM
•
Bluebird 2E
F058 How to Approach Challenges in Hidradenitis Suppurativa Management: Strategies to Optimize Use of HS Therapies
Mar 29, 2026
•
1:00 PM - 3:00 PM
•
Bluebird 1B
DISCLOSURES
Incyte – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Novartis – Advisory Board(Honoraria); Novartis Pharmaceuticals Corp. – Investigator(Grants/Research Funding);